Condominium Common Element For Neurodegenerative Diseases In New York
Description
Form popularity
FAQ
It is apparent that the effects of certain well known and long respected environmental toxins such as lead, mercury, etc., deserve continued surveillance. In addition, the overwhelming impact on the CNS of social damages such as trauma, alcohol, and tobacco cannot be ignored by environmentalists.
Examples of specific toxicants affecting the peripheral nervous system (PNS) include, but are not limited to, organic solvents (n-hexane, trichloroethylene, methyl-n-butyl ketone, toluene, and styrene), industrial chemicals (carbon disulfide, dimethylaminoproprionitrile, and acrylamide), metals (arsenic, organic ...
Hallmarks of neurodegeneration. Neuroimmune alterations, disrupted proteostasis, oxidative and endoplasmic reticulum stress, and metabolic dysfunction are key components that could be primary submodels in a platform quantitative systems pharmacology (QSP) model of neurodegenerative diseases.
Parkinson's disease. Alzheimer's disease. Huntington's disease. Amyotrophic lateral sclerosis (ALS)
In recent studies, air pollution has been linked to cognitive decline and neurodegenerative diseases, such as Parkinson's disease (PD) and Alzheimer's disease (AD) (Allen et al., 2017). This growing body of research underscores the urgent need to explore the impact of air pollution on mental health and public safety.
The specific causes of neurological problems vary, but can include genetic disorders, congenital abnormalities or disorders, infections, lifestyle or environmental health problems including malnutrition, and brain injury, spinal cord injury or nerve injury.
Alzheimer's disease and Parkinson's disease are the most common neurodegenerative diseases. In the United States, as many as 6.2 million people may have Alzheimer's disease, ing to a report from the Alzheimer's Disease Association in 2022.
As the disease progresses over the typical 7–10 years from onset to death (AD is universally fatal), eventually other brain areas are affected and the individual loses the ability to control sphincters, swallow, talk, or walk.
Neurodegenerative diseases are fatal and we have no disease-modifying therapies.
Conditions Alzheimer's disease and other memory disorders. Ataxia. Huntington's disease. Parkinson's disease. Motor neuron disease. Multiple system atrophy. Progressive supranuclear palsy.
